Back to LBRX

CITADEL ADVISORS LLC → LBRX

CITADEL ADVISORS LLC LBRX Position History

LB Pharmaceuticals Inc • Healthcare

Quarters held
13
Latest value
$729K
Q3 2026
Peak value
$10M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$8.4M
Q3 2025$106K
Q4 2025$9.1M
Q1 2026$10M
Q1 2026$276K
Q2 2026$2.2M
Q2 2026$4.8M
Q2 2026$2.2M
Q2 2026$4.8M
Q3 2026$1.1M
Q3 2026$1.1M
Q3 2026$7.6M
Q3 2026$729K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$729K19.0K——
Q3 2026$7.6M197.7K——
Q3 2026$1.1M28.5K——
Q3 2026$1.1M27.5K——
Q2 2026$4.8M146.7K——
Q2 2026$2.2M69.3K——
Q2 2026$4.8M146.7K——
Q2 2026$2.2M69.3K——
Q1 2026$276K11.2K——
Q1 2026$10M405.7K——
Q4 2025$9.1M407.7K——
Q3 2025$106K6.7K——
Q3 2025$8.4M532.7K——

Other funds holding LBRX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B